Clinical Guides
Tropical Sprue
A clinically focused guide to the exclusion diagnosis of tropical sprue in India, integrating malabsorption, intestinal biopsy, antimicrobial therapy, nutritional repair and important mimics.
MedNext Academy | 13 min read
Tropical Sprue
A clinically focused guide to the exclusion diagnosis of tropical sprue in India, integrating malabsorption, intestinal biopsy, antimicrobial therapy, nutritional repair and important mimics.
Summary
Tropical sprue is an acquired small-intestinal enteropathy associated with residence in or prolonged exposure to certain tropical regions. It causes persistent diarrhoea, weight loss and malabsorption, often with folate and vitamin B12 deficiency. The cause is not proven; post-infectious mucosal injury and altered small-bowel microbiota are leading models, not established single-pathogen explanations. Its apparent frequency has fallen or changed geographically, and modern high-quality trials are scarce. The label must therefore be earned through a compatible exposure and syndrome, objective evidence of malabsorption, supportive small-bowel histology where feasible, exclusion of better-defined causes and sustained response to nutritional plus antimicrobial treatment.
There is no diagnostic blood test and no biopsy feature unique to tropical sprue. Coeliac disease, giardiasis and other parasites, small-intestinal bacterial overgrowth, HIV-related enteropathy, tuberculosis, Crohn disease, pancreatic insufficiency, medication injury, immune deficiency and intestinal lymphoma can produce overlapping symptoms or villous blunting. A temporary response to folate or antibiotics is not proof, because deficiencies improve with replacement and several infections or bacterial-overgrowth states respond to the same drugs.
Management corrects dehydration, electrolytes, protein-energy malnutrition, anaemia and defined micronutrient deficits while a gastroenterology-led work-up excludes mimics. Tetracycline-class therapy plus folate has the longest historical experience, but regimen and duration evidence comes mainly from old observational studies, small cohorts and expert reviews. Pregnancy, childhood, antimicrobial resistance and adverse effects require individualized alternatives. This educational draft is has been reviewed by the MedNext Clinical Team, remains reviewed and must not be used as a shortcut around investigation of chronic diarrhoea or malignancy.
How Common Is It?
The true contemporary incidence of tropical sprue is unknown. Historic endemic areas included parts of India and South and Southeast Asia, the Caribbean and sections of Central and South America. Reports described both sporadic disease and outbreaks, sometimes following an acute diarrhoeal illness. More recent Indian tertiary cohorts still identify tropical sprue among adults with chronic small-bowel diarrhoea and malabsorption, but proportions vary sharply with referral selection, definitions, access to coeliac serology and biopsy, and how thoroughly infections are excluded. These studies cannot establish community prevalence.
Residents can develop prolonged or recurrent disease, whereas travellers may present after leaving the exposure region. There is no reliable minimum travel duration that acts as a diagnostic threshold; the exposure history should include exact destinations, rural or urban stay, food and water conditions, preceding gastroenteritis, antibiotics and symptom chronology. Tropical sprue is reported in adults more often than young children, but childhood malabsorption needs paediatric assessment rather than assumption that the diagnosis is impossible.
Recognition can move in both unsafe directions. In low-prevalence settings, the diagnosis may be missed because clinicians do not ask where a patient lived. In endemic settings, any chronic diarrhoea and anaemia may be over-labelled as sprue, delaying coeliac disease, parasitic infection, tuberculosis or cancer. Modern molecular pathogen panels and high-quality endoscopy have changed competing diagnoses faster than the tropical-sprue evidence base itself. Services should audit final diagnoses, nutritional recovery, relapses and alternative conditions found during follow-up, and report denominators and diagnostic criteria instead of advertising a local percentage as an Indian national rate.
Risk Factors
The essential epidemiological clue is residence in or substantial exposure to a region where tropical sprue has been described. Rural living, unsafe water, inadequate sanitation, crowding and a preceding episode of acute gastroenteritis may increase exposure to enteric organisms, but no organism has been proved to cause every case. Seasonal or epidemic patterns and response to antibiotics support an infectious contribution; mucosal, immune and nutritional factors probably modify susceptibility. A traveller, migrant or returning resident can remain symptomatic after leaving the tropics.
Risk of severe consequences rises with delayed presentation, low dietary reserve, food insecurity, repeated enteric infection, pregnancy, older age and comorbid disease. Folate depletion may appear relatively early, while prolonged ileal dysfunction can produce vitamin B12 deficiency with irreversible neurological injury if missed. Fat malabsorption may deplete vitamins A, D, E and K; protein loss can cause oedema. Lactase activity may fall after mucosal injury, making dairy worsen symptoms without being the primary disease. These consequences are not specific to tropical sprue and must not be used circularly to confirm it.
Several factors instead increase the probability of a competing diagnosis: family history or autoimmunity for coeliac disease; contaminated water or daycare exposure for giardiasis; HIV or immunosuppressive treatment for opportunistic infection; previous gastric or intestinal surgery for bacterial overgrowth; alcohol or pancreatic disease for exocrine insufficiency; and olmesartan, mycophenolate or other medicines for drug-related enteropathy. Fever, night sweats, abdominal mass, bleeding or focal obstruction raises concern for tuberculosis, Crohn disease or malignancy. Risk assessment should widen testing, not preselect the answer.
Diagnosis
History
Define stool frequency, duration, nocturnal symptoms, volume, blood, mucus, greasy appearance, flushing difficulty and relation to food or fasting. Chart weight change, appetite, bloating, fever, pain, vomiting, mouth ulcers, bone pain, bruising, oedema, neuropathy and menstrual or pregnancy history. Record every residence and journey, sanitation and water exposure, preceding gastroenteritis, sexual risks, HIV testing, tuberculosis contact, medications, surgery, alcohol and family coeliac or inflammatory-bowel disease. Ask what happened during gluten restriction, antibiotics and supplements without treating response as proof.
Examination
Measure weight, height, body-mass index, mid-arm or other validated nutritional indices, temperature, pulse, blood pressure and orthostatic change. Seek pallor, glossitis, angular cheilitis, mouth ulcers, oedema, muscle wasting, bruising and hyperpigmentation. Examine abdomen for tenderness, organomegaly, ascites or mass; look for perianal disease. Assess vibration, joint position, gait and reflexes for B12-related neurological injury. Lymphadenopathy, fever or a mass shifts priority toward infection or malignancy.
Investigations
Start with blood count and film, ferritin and iron indices, folate, B12, albumin, liver and renal profiles, calcium, phosphate, magnesium, CRP, thyroid testing and coagulation where indicated. Test coeliac serology while the patient eats gluten, including total IgA. Use repeated or targeted stool testing for Giardia and other parasites, culture or molecular studies according to exposure, and HIV testing with consent. Quantify or otherwise establish malabsorption when uncertainty remains. Upper endoscopy with multiple duodenal biopsies can show partial villous blunting, crypt change and inflammation, but findings are non-specific. Image bowel, pancreas or nodes when alarm features suggest structural disease. Tropical sprue remains a diagnosis of exclusion plus longitudinal confirmation.
Differential Diagnosis
Coeliac disease is the principal immune-mediated mimic. Check tissue-transglutaminase IgA with total IgA while gluten is consumed; use IgG-based testing when IgA deficient, and interpret biopsy orientation and distribution carefully. Tropical sprue often affects more distal small bowel and may show less complete villous atrophy, but overlap prevents diagnosis by morphology alone. Do not prescribe lifelong gluten avoidance because serology was obtained after dietary restriction or because an empiric diet produced non-specific change. Reconcile genetics, serology, histology and response with a gastroenterologist.
Infectious exclusions are central in India: Giardia, Cryptosporidium, Cystoisospora, Strongyloides and other parasites; intestinal tuberculosis; HIV-associated infection; and persistent bacterial disease according to exposure. Repeated stool antigen, PCR, concentration methods, duodenal sampling or tissue stains may be needed because one microscopy result has limited sensitivity. Small-intestinal bacterial overgrowth can coexist with sprue or arise from surgery, dysmotility and blind loops, making antibiotic response especially non-specific. Environmental enteric dysfunction and severe dietary malnutrition are related population problems but are not interchangeable adult clinical labels.
Non-infectious causes include Crohn disease, microscopic colitis, bile-acid diarrhoea, pancreatic exocrine insufficiency, chronic pancreatitis, autoimmune enteropathy, common variable immunodeficiency, eosinophilic enteritis, Whipple disease and medication-induced enteropathy. Intestinal lymphoma, small-bowel adenocarcinoma, pancreatic cancer and other malignancy must be considered with older age, rapid weight loss, bleeding, mass, obstruction, nodes or treatment failure. A diagnosis of functional diarrhoea is unsafe until organic alarm features and deficiencies are explained. Lack of durable recovery should reopen the entire differential rather than trigger indefinite antibiotics.
Management
Correct immediate physiological deficits before pursuing a neat label. Oral rehydration is appropriate when absorption and circulation are adequate; severe dehydration, hypotension, renal injury or major electrolyte disturbance needs hospital-based intravenous replacement and monitoring. Obtain dietetic assessment, a weight trajectory and refeeding-risk evaluation. Replace folate and vitamin B12, but if both could be deficient do not give folate alone before protecting against B12-related neurological progression. Replete iron, calcium, magnesium and fat-soluble vitamins when deficiency is demonstrated or strongly suspected, and provide sufficient energy and protein using affordable foods or enteral support.
Historical treatment combines an oral tetracycline-class antibiotic with folic acid. Travellers with shorter disease have often received shorter courses, whereas residents with longstanding illness have been treated for several months; the optimal drug and duration are not established by contemporary large randomized trials. Choose regimen with gastroenterology or infectious-disease input after excluding pathogens requiring specific therapy and reviewing pregnancy, age, kidney and liver function, local resistance, previous antimicrobial exposure and adherence feasibility. Trimethoprim-sulfamethoxazole has been used as an alternative, but it also has contraindications and monitoring needs.
Track outcomes that test the working diagnosis: stool frequency and consistency, weight, appetite, hydration, haemoglobin, mean cell volume, albumin, folate and B12, plus neurological findings. Symptomatic improvement may begin quickly, whereas mucosal and nutritional recovery take longer. Treat identified lactose intolerance temporarily if helpful, then reassess dietary breadth. Failure to improve demands review of adherence, ongoing exposure, resistant or wrong infection, coeliac disease, tuberculosis, pancreatic disease and malignancy. Repeated empiric courses without diagnostic reconsideration are poor antimicrobial stewardship.
Prescribing Information
Tetracycline and doxycycline have the longest reported experience, but selection is not interchangeable across patients. Review pregnancy or breastfeeding, age, renal and hepatic function, oesophageal disease, photosensitivity, allergy and interacting medicines. Tetracyclines can cause nausea, pill oesophagitis and photosensitivity; administration instructions and separation from iron, calcium and antacids matter because chelation reduces absorption. Avoid casual tetracycline use during pregnancy and in young children; specialist-selected alternatives must account for the same diagnostic uncertainty rather than being presented as harmless substitutes.
Trimethoprim-sulfamethoxazole can cause rash, severe cutaneous reactions, cytopenia, renal effects and hyperkalaemia, and interacts with medicines including warfarin and renin-angiotensin system agents. Check allergy, pregnancy status, blood count, renal function, potassium and interaction risk as clinically indicated. Fluoroquinolones appear in some historical or secondary discussions but carry important tendon, neurological, cardiac and resistance harms and should not become an automatic replacement. Culture or pathogen-directed therapy takes precedence when a specific infection is found.
Folate can correct megaloblastic anaemia while masking untreated B12 deficiency, so assess and replace B12 whenever plausible. Neurological symptoms justify prompt parenteral B12 according to an approved regimen rather than waiting for every test. Iron therapy, calcium and fat-soluble vitamins should follow deficiency, tolerance and monitoring needs. Document an antimicrobial stop or review date, response criteria and ownership. Long courses increase C. difficile, candidiasis, drug toxicity and resistance risk. Evidence for exact tropical-sprue regimens is dated and geographically heterogeneous; a historical dose is not a universal modern prescription.
When to Refer
Arrange urgent assessment for haemodynamic instability, severe dehydration, acute kidney injury, major electrolyte disturbance, inability to eat or drink, gastrointestinal bleeding, peritonism, sepsis, symptomatic severe anaemia or rapidly progressive neurological findings. Marked oedema, very low albumin, extreme weight loss or high refeeding risk may require admission even when vital signs initially look acceptable. Children, pregnancy, immunosuppression and frail older adults need earlier specialist review because differentials, drug safety and nutritional consequences differ.
Refer persistent diarrhoea with weight loss, anaemia, hypoalbuminaemia or objective malabsorption to gastroenterology. The referral should include a dated travel and residence history, stool characterization, weight trajectory, dietary and medication exposures, laboratory results, coeliac testing conditions, stool methods and every empiric treatment already tried. Endoscopy is needed when mucosal disease remains likely; multiple properly oriented duodenal biopsies and pathology context improve interpretation. Infectious-disease or microbiology input is appropriate for complex parasites, HIV, tuberculosis, antimicrobial resistance or recurrent post-travel illness.
Escalate to an intestinal-failure or specialist nutrition service when oral intake cannot restore weight and micronutrients, when parenteral support is considered or when severe protein-energy malnutrition persists. Cancer-pathway evaluation is necessary for a mass, obstruction, bleeding, pathological nodes, unexplained iron deficiency, constitutional deterioration or an atypical biopsy. If a presumed tropical sprue case does not show sustained objective recovery, request pathology review and re-open imaging and infection testing. The referring clinician retains safety-netting responsibility; a months-long antibiotic course without a named follow-up date is not a safe referral plan.
Red Flags
Shock, syncope, oliguria, confusion, persistent vomiting and profound weakness may reflect severe volume or electrolyte depletion. Hypokalaemia and hypomagnesaemia can precipitate arrhythmia; hypocalcaemia can cause tetany or seizures. Severe anaemia may produce dyspnoea, chest pain or cardiac strain. New gait disturbance, loss of vibration or position sense, weakness, cognitive change or visual symptoms can represent advanced B12 or other nutritional injury and requires prompt assessment before folate-only treatment obscures haematological clues.
Blood in stool, nocturnal pain, persistent fever, a palpable abdominal mass, progressive dysphagia, obstruction, ascites or rapidly accelerating weight loss is not typical uncomplicated tropical sprue. These features demand evaluation for inflammatory bowel disease, intestinal tuberculosis, lymphoma, gastrointestinal or pancreatic malignancy and other structural pathology. Generalised lymphadenopathy, hepatosplenomegaly or markedly raised inflammatory markers similarly weakens a simple sprue explanation. Coeliac serology can be falsely negative with IgA deficiency or gluten restriction; a negative result obtained under the wrong conditions is another diagnostic red flag.
Treatment failure means no sustained objective improvement in stool pattern, weight and biochemical deficiencies after an adequate, adhered-to plan. Do not respond with endless antibiotic extension. Check the diagnosis, ongoing exposure, medicine absorption, resistant or untreated pathogens and adverse drug effects. Severe rash, mucosal lesions, fever with cytopenia, rising creatinine, hyperkalaemia, jaundice, tendon pain or neurological symptoms during antimicrobial treatment requires urgent medication review. Relapse after return to an endemic environment may be recurrence or re-exposure, but malignancy and chronic infection still require exclusion rather than narrative convenience.
Indian Clinical Context
India has both genuine tropical enteropathy and a wide range of more clearly defined causes of chronic diarrhoea. Coeliac disease is well established in northern India and occurs elsewhere; giardiasis, strongyloidiasis, tuberculosis and HIV-related disease remain relevant; diabetes, alcohol-related pancreatic disease and gastrointestinal malignancy add age-dependent alternatives. Calling the syndrome tropical because the patient is Indian is diagnostically empty. Record residence, sanitation exposure, preceding infection and objective malabsorption, and establish what has actually been excluded.
Diagnostic access is uneven. A district service may have blood count, albumin, basic stool microscopy and ultrasound but lack stool antigen or PCR, total IgA, endoscopy, expert histopathology, faecal elastase or enterography. Sequence the most decision-changing accessible tests, preserve biopsy material for review and refer early when alarm features or severe malnutrition exceed local capability. One negative stool sample is not a comprehensive infection screen, while an empiric antimicrobial response is not a substitute for biopsy and cancer assessment when those are clinically indicated.
Nutrition plans must be affordable, culturally acceptable and measurable. Involve a dietitian where available, use locally obtainable protein and energy sources, correct B12 and folate safely, and document weight and laboratory follow-up. Antimicrobial availability does not erase stewardship: prolonged therapy carries toxicity, cost and resistance, and evidence for the traditional regimen predates present resistance ecology. Travel distance, loss of wages and medicine supply interruptions influence adherence; provide a named local follow-up clinician and explicit failure criteria. Indian research should use reproducible definitions and prospective follow-up, because contemporary incidence, optimal regimen and relapse prevention remain important evidence gaps.
NMC Competency Mapping
Tropical sprue is best taught as an integrated malabsorption problem rather than a one-line eponym. General-medicine and gastroenterology outcomes include taking a structured chronic-diarrhoea and travel history, recognizing organic alarm features, assessing hydration and nutrition, constructing a differential and interpreting blood, stool, serological, imaging and biopsy evidence. Pathology learning should compare partial villous blunting, crypt change and lamina-propria inflammation across tropical sprue, coeliac disease, infection and drug injury, emphasizing that morphology needs clinical context.
Microbiology competencies include correct stool collection, the limits of single microscopy, selection of antigen or molecular tests and recognition of Giardia, Strongyloides, coccidian parasites, HIV-associated pathogens and intestinal tuberculosis. Pharmacology should cover tetracycline and trimethoprim-sulfamethoxazole safety, interactions, stewardship and the hazard of extrapolating old regimens. Biochemistry connects folate and B12 absorption to megaloblastic anaemia, neurological injury and the danger of folate-only replacement. Community medicine adds safe water, sanitation, nutrition and critical interpretation of hospital-series epidemiology.
Assessment can use a case-based discussion requiring the learner to prove malabsorption, state exclusions and design follow-up with objective endpoints. An observed encounter can assess hydration, nutritional examination and communication about HIV, diet or travel without stigma. A prescription exercise should include contraindication and interaction checks rather than marks for a memorized dose. Learners should explicitly say when endoscopy, specialist nutrition or cancer evaluation is needed. This maps transferable competencies and does not claim that every named manifestation has a dedicated code in the NMC curriculum.
Key Exam Pearls for NEET PG
Think of tropical sprue when chronic non-bloody diarrhoea, steatorrhoea, weight loss and megaloblastic anaemia follow residence in an endemic tropical region. Folate deficiency may appear early; vitamin B12 deficiency and neurological consequences can emerge with longer disease. Histology commonly shows partial villous blunting, crypt elongation and chronic inflammatory infiltration, but these findings are not pathognomonic. Disease may extend beyond the proximal bowel, unlike the classic proximal predominance taught for coeliac disease, yet location alone cannot decide the diagnosis.
The diagnostic phrase to remember is diagnosis of exclusion with objective malabsorption. Exclude coeliac disease under valid testing conditions, Giardia and other parasites, bacterial overgrowth, HIV-related disease, tuberculosis, Crohn disease, pancreatic insufficiency, drug injury, immune deficiency and malignancy. A response to antibiotics plus folate supports the diagnosis only when it is durable and competing explanations have been addressed. Folate response alone can improve anaemia in several conditions and can mask B12 deficiency.
Traditional therapy uses a tetracycline-class antimicrobial plus folate, with B12 and other nutritional replacement as indicated. Treatment duration is often longer for endemic residents with longstanding disease than for travellers, but the evidence is old and does not justify one universal schedule. Avoid tetracyclines in pregnancy and young children unless a specialist-supported indication and safe choice exists. Persistent bleeding, fever, mass, obstruction, severe hypoalbuminaemia, neurological signs or treatment failure should trigger urgent reassessment. The highest-yield distinction is intellectual: tropical exposure raises probability; it never replaces exclusion of a treatable infection, coeliac disease or cancer.
Frequently Asked Questions
Is there a single definitive test that proves tropical sprue?
No. Diagnosis requires a compatible geographical and clinical history, objective malabsorption, supportive but non-specific small-bowel findings where available, deliberate exclusion of defined infections and enteropathies, and sustained objective response to treatment. Neither one biopsy appearance nor improvement after folate or antibiotics is unique to tropical sprue.
How is tropical sprue distinguished from coeliac disease?
Test coeliac serology with total IgA while gluten is being eaten, obtain properly oriented multiple duodenal biopsies and interpret distribution, severity and response in context. Tropical exposure and distal involvement can support sprue, but histology overlaps. A gastroenterologist should reconcile serology, diet history, pathology and longitudinal response.
Why must vitamin B12 be considered before prescribing folate alone?
Folate may correct megaloblastic anaemia while neurological injury from vitamin B12 deficiency continues. Longstanding malabsorption can deplete both. Assess B12, examine for neuropathy or posterior-column dysfunction and replace urgently when clinically indicated; do not delay protective treatment in a symptomatic patient while waiting for every result.
What should happen when presumed tropical sprue does not improve?
Verify adherence, dose delivery, nutrition and ongoing exposure, then reopen the diagnosis rather than extending antibiotics indefinitely. Reassess coeliac testing conditions, parasites, bacterial overgrowth, HIV, tuberculosis, inflammatory bowel disease, pancreatic insufficiency, drug injury, immune deficiency and gastrointestinal malignancy, with specialist pathology or imaging review where indicated.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic